miR-155 in acute myeloid leukemia: Not merely a prognostic marker?

Journal of Clinical Oncology

Volumn 31, Issue 17, 2013, Pages 2219-2221

  Joyce, Cailin E ^a   Novina, Carl D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MICRORNA 155; MICRORNA; MIRN155 MICRORNA, HUMAN;

ACUTE MYELOID LEUKEMIA; ARTICLE; CANCER PROGNOSIS; GENE EXPRESSION; GENE REPRESSION; HOMEOSTASIS; HUMAN; LEUKEMOGENESIS; NONHUMAN; PRIORITY JOURNAL; RNA TRANSLATION; ACUTE GRANULOCYTIC LEUKEMIA; FEMALE; GENETICS; MALE;

FEMALE; HUMANS; LEUKEMIA, MYELOID, ACUTE; MALE; MICRORNAS;

EID: 84891454338     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.48.3180     Document Type: Article

References (23)

1. Lujambio A, Lowe SW: The microcosmos of cancer. Nature 482:347-355, 2012
2. Lu J, Getz E, Miska G, et al: MicroRNA expression profiles classify human cancers. Nature 435:834-838, 2005
3. Garzon R, Garofalo M, Martelli M, et al: Distinctive microRNA signature of acute myeloid leukemia bearing cytoplasmic mutated nucleo-phosmin. Proc Natl Acad Sci U S A 105:3945-3950, 2008
4. Eis PS, Tam W, Sun L, et al: Accumulation of miR-155 and BIC RNA in human B cell lymphomas. Proc Natl Acad Sci U S A 102:3627-3632, 2005
5. Volinia S, Calin GA, Liu CG, et al: A microRNA expression signature of human solid tumors defines cancer gene targets. Proc Natl Acad Sci U S A 103:2257-2261, 2006
6. Marcucci G, Maharry KS, Metzeler KH, et al: Clinical role of microRNAs in cytogenetically normal acute myeloid leukemia: miR-155 upregulation independently identifies high-risk patients. J Clin Oncol 31:2086-2093, 2013
7. O’Connell RM, Taganov KD, Boldin MP, et al: MicroRNA-155 is induced during the macrophage inflammatory response. Proc Natl Acad Sci U S A 104:1604-1609, 2007
8. Nagai Y, Garrett KP, Ohta S, et al: Toll-like receptors on hematopoietic progenitor cells stimulate innate immune system replenishment. Immunity 24:801-812, 2006
9. O’Connell RM, Rao DS, Chaudhuri AA, et al: Sustained expression of microRNA-155 in hematopoietic stem cells causes a myeloproliferative disorder. J Exp Med 205:585-594, 2008
10. Ghani S, Riemke J, Schönheit J, et al: Macrophage development from HSCs requires PU. 1-coordinated microRNA expression. Blood 118: 2275-2284, 2011
11. Scott EW, Simon MC, Anastasi J, et al: Requirement of transcription factor PU. 1 in the development of multiple hematopoietic lineages. Science 265:1573-1577, 1994
12. Rosenbauer F, Wagner K, Kutok JL, et al: Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU. 1. Nat Genet 36:624-630, 2004
13. O’Connell RM, Kahn D, Gibson WS, et al: MicroRNA-155 promotes autoimmune inflammation by enhancing inflammatory T cell development. Immunity 33:607-619, 2010
14. Androulidaki A, Iliopoulos D, Arranz A, et al: The kinase Akt1 controls macrophage response to lipopolysaccharide by regulating microRNAs. Immunity 31:220-231, 2009
15. Luo JM, Liu ZL, Hao HL, et al: Mutation analysis of SHIP gene in acute leukemia. Zhongguo Shi Yan Xue Ye Xue Za Zhi 12:420-426, 2004
16. Chen CY, Tsay W, Tang JL, et al: SOCS1 methylation in patients with newly diagnosed acute myeloid leukemia. Genes Chromosomes Cancer 37:300-305, 2003
17. Krek A, Grün D, Poy MN, et al: Combinatorial microRNA target predictions. Nat Genet 37:495-500, 2005
18. Lewis BP, Burge CB, Bartel DP: Conserved seed pairing, often flanked by adenosines, indicates that thousands of human genes are microRNA targets. Cell 120:15-20, 2005
19. Friedman RC, Farh KK, Burge CB, et al: Most mammalian mRNAs are conserved targets of microRNAs. Genome Res 19:92-105, 2009
20. Loeb GB, Khan AA, Canner D, et al: Transcriptome-wide miR-155 binding map reveals widespread noncanonical microRNA targeting. Mol Cell 48:760-770, 2012
21. Elmń J, Lindow M, Schütz S, et al: LNA-mediated microRNA silencing in non-human primates. Nature 452:896-899, 2008
22. Lanford RE, Hidebrandt-Eriksen ES, Petri A, et al: Therapeutic silencing of microRNA-122 in primates with chronic hepatitis C virus infection. Science 327:198-201, 2010
23. Lee H, Lytton-Jean AK, Chen Y, et al: Molecularly self-assembled nucleic acid nanoparticles for targeted in vivo siRNA delivery. Nat Nanotechnol 7:389-393, 2012